Medicare Part D Coverage Determinations: A Clinician's Guide (2026)
How Medicare Part D coverage determinations work in 2026: exception requests, tiering exceptions, and appeals for denied medications.
What Is a Coverage Determination?
A Medicare Part D coverage determination is the plan's initial decision about whether a drug is covered, at what cost-share, and under what conditions. Clinicians request coverage determinations when a patient needs a drug that is non-formulary, requires prior authorization, has quantity limits, or is placed on a higher tier than the patient can afford.
The request can be initiated by the beneficiary, the beneficiary's appointed representative, or the prescribing clinician. In practice, clinician-initiated requests move faster, because nearly every exception category requires a prescriber supporting statement before the plan can act. A beneficiary calling the plan alone will simply trigger an outreach request back to the prescriber, adding days to the timeline.
This is the step that precedes any appeal. The five-level Medicare appeals process does not begin until a coverage determination has been issued and denied, which is why getting the initial request right matters more than most practices treat it. A well-documented first submission avoids weeks of downstream appeal work.
Types of Requests
There are four main request types, and choosing the right one determines which criteria the plan applies:
- ✓ Formulary exception (drug is non-formulary) — requires a prescriber statement that formulary alternatives would be less effective or cause adverse effects
- ✓ Tiering exception (drug is covered but on a high-cost tier) — moves the drug to a lower cost-sharing tier
- ✓ Prior authorization (drug is on formulary but requires PA) — requires documentation against the plan's published criteria
- ✓ Quantity limit exception (prescribed amount exceeds the plan limit) — requires clinical rationale for the higher quantity
Standard vs. Expedited Timelines
Medicare sets strict decision timelines: 24 hours for expedited requests and 72 hours for standard requests. A request qualifies for expedited handling when applying the standard timeframe could seriously jeopardize the patient's life, health, or ability to regain maximum function. When a prescriber indicates that the expedited standard is met, the plan must grant expedited processing.
The detail that trips up most practices is when the clock actually starts. For exception requests, the decision window does not begin when the patient calls the plan — it begins when the plan receives the prescriber's supporting statement. A request submitted Monday without that statement may not start its 72-hour clock until Thursday. Submitting the clinical rationale simultaneously with the request is the single highest-leverage timing decision in the process.
Plans that miss these deadlines must forward the request to the Independent Review Entity for review. This auto-forward is a beneficiary protection, not a strategy to rely on — it adds time rather than saving it.
What to Include in the Request
A complete coverage determination request includes the patient's demographics and Medicare ID, the requested drug with dose and duration, the clinical diagnosis with ICD-10 code, documentation of why formulary alternatives are inappropriate, and prescriber attestation.
The formulary-alternative documentation is where most requests fail. A statement that the patient "needs" the requested drug carries no weight. What Medicare reviewers look for is drug-specific history: the alternatives tried, the dose and duration of each trial, the objective reason for discontinuation, and — where the patient has not tried an alternative — the specific contraindication, interaction, or comorbidity that makes the trial inappropriate.
Where an alternative was never tried, say so explicitly and explain why. Reviewers treat silence as an incomplete record and deny on that basis; a documented clinical reason for skipping a step is routinely accepted.
Tiering Exceptions: The Underused Tool
A tiering exception moves a drug from a higher cost tier to a lower one when formulary alternatives on the lower tier would be ineffective or cause adverse effects. Most clinicians forget this tool exists. Where it applies, it can substantially reduce a patient's monthly copay without changing the drug, the pharmacy, or the prescription.
There are meaningful limits worth knowing before you spend time on the request. Plans are generally not required to grant tiering exceptions that would move a drug below the tier of the alternatives being compared against, and many plans exclude their specialty tier from tiering exceptions entirely. Check the plan's Evidence of Coverage for the specialty-tier carve-out before submitting — it is the most common reason an otherwise well-documented tiering request is denied.
When a tiering exception is unavailable, the fallback options are a formulary exception for a lower-tier therapeutic alternative, or referral to patient assistance and manufacturer copay support.
Transition Fills: The 90-Day Window Most Practices Miss
New Part D enrollees, and continuing enrollees affected by a formulary change at the plan year boundary, are entitled to a temporary transition supply of a non-formulary drug during the early part of their enrollment. The intent is to prevent an abrupt therapy interruption while a coverage determination is pending.
This matters operationally because it buys time. A patient who switches plans in January and discovers their maintenance biologic is non-formulary does not have to choose between paying cash and stopping therapy — the transition fill covers the gap while the exception request is processed. Practices that know to ask for it convert a crisis into a scheduled task.
The transition supply is a bridge, not a solution. It does not substitute for a coverage determination, and it does not repeat indefinitely. Use the window to submit a properly documented exception request.
The 5-Level Appeals Process
If the initial determination is denied, Medicare beneficiaries have five levels of appeal. Each level has its own filing deadline and its own decision timeline:
- ✓ Level 1: Redetermination by the plan — generally filed within 60 days of the denial notice; 7 days standard, 72 hours expedited
- ✓ Level 2: Reconsideration by an Independent Review Entity (IRE), an outside reviewer not employed by the plan
- ✓ Level 3: Administrative Law Judge hearing through the Office of Medicare Hearings and Appeals, available when the amount in controversy meets the annual threshold
- ✓ Level 4: Medicare Appeals Council review
- ✓ Level 5: Federal District Court, subject to a higher amount-in-controversy threshold
Common Reasons for Denial
The most common denial reasons are missing clinical justification, insufficient documentation of prior therapy trials, and requests that don't address the plan's specific formulary criteria. Each is fixable with a targeted resubmission rather than a full appeal.
A fourth category is procedural rather than clinical: the request was submitted without the prescriber supporting statement, or under the wrong request type. A tiering exception filed for a drug on an excluded specialty tier will be denied regardless of how strong the clinical rationale is. Reading the denial notice carefully to determine whether the rejection was clinical or procedural determines whether you resubmit or appeal.
Before escalating to a Level 1 redetermination, confirm the denial was substantive. Resubmitting a corrected request is usually faster than appealing a request that was never complete.
How RxCheckUp Supports Part D Requests
RxCheckUp pulls the specific Medicare Part D plan's formulary, drafts coverage determination requests that align with CMS requirements, and automatically includes the clinical evidence and prior therapy documentation that Medicare reviewers expect.
The platform flags which request type applies before you submit, surfaces the plan's published criteria for the requested drug, and structures the prior-therapy history in the format reviewers look for — reducing the procedural denials that send otherwise valid requests back to the start of the process.